Vimarsana
Biggest News Aggregation in the World

Page 12 - Wealth Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wealth Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wealth Effects Today - Breaking & Trending Today

First National Advisers LLC Makes New Investment in Vanguard S&P 500 ETF (NYSEARCA:VOO) - Vimarsana News

First National Advisers LLC Makes New Investment in Vanguard S&P 500 ETF (NYSEARCA:VOO)

First National Advisers LLC acquired a new position in Vanguard S&P 500 ETF (NYSEARCA:VOO – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 8,745 shares of the company’s stock, valued at approximately $3,820,000. Vanguard S&P 500 ETF makes […]

Source: wkrb13.com
First Trust Small Cap Growth AlphaDEX Fund (NASDAQ:FYC) Shares Down 0.6% - Vimarsana News

First Trust Small Cap Growth AlphaDEX Fund (NASDAQ:FYC) Shares Down 0.6%

Shares of First Trust Small Cap Growth AlphaDEX Fund (NASDAQ:FYC – Get Free Report) fell 0.6% during trading on Thursday . The company traded as low as $66.98 and last traded at $67.07. 6,123 shares were traded during mid-day trading, a decline of 75% from the average session volume of 24,779 shares. The stock had […]

National Bank of Canada FI Purchases 4,264 Shares of Trane Technologies plc (NYSE:TT) - Vimarsana News

National Bank of Canada FI Purchases 4,264 Shares of Trane Technologies plc (NYSE:TT)

National Bank of Canada FI raised its stake in shares of Trane Technologies plc (NYSE:TT – Free Report) by 2.4% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 182,557 shares of the company’s stock after purchasing an additional 4,264 shares during the period. National Bank of Canada […]

HC Wainwright Boosts TG Therapeutics (NASDAQ:TGTX) Price Target to $49.00 - Vimarsana News

HC Wainwright Boosts TG Therapeutics (NASDAQ:TGTX) Price Target to $49.00

TG Therapeutics (NASDAQ:TGTX – Free Report) had its price objective increased by HC Wainwright from $45.00 to $49.00 in a research report report published on Thursday morning, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. Several other analysts have also recently issued reports on the stock. The Goldman Sachs […]

Beyond Air (NASDAQ:XAIR) Given New $8.00 Price Target at Truist Financial - Vimarsana News

Beyond Air (NASDAQ:XAIR) Given New $8.00 Price Target at Truist Financial

Beyond Air (NASDAQ:XAIR – Free Report) had its price objective reduced by Truist Financial from $10.00 to $8.00 in a report released on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. Beyond Air Trading Up 6.6 % Shares of Beyond Air stock opened at $1.30 on Tuesday. Beyond Air has […]

Source: wkrb13.com